L 888607 Racemate
|
1030017-51-6
|
1030017-51-6
|
GKT136901
|
AK120765
|
955272-06-7
|
VTX-27
|
1321924-70-2
|
1321924-70-2
|
TNF-α-IN-1
|
TNF-Α-IN-1
|
444287-49-4
|
YKL-05-099
|
化合物YKL-05-099
|
1936529-65-5
|
S1p receptor agonist 1
|
CS-2465
|
1514888-56-2
|
GSK-872
|
GSK872
|
1346546-69-7
|
LY2955303
|
CS-2631
|
1433497-19-8
|
PF-4191834
|
化合物 T16503
|
1029317-21-2
|
Brensocatib
|
AZD7986
|
1802148-05-5
|
C-176
|
N-(4-碘苯基)-5-硝基呋喃-2-甲酰胺
|
314054-00-7
|
APX-115
|
化合物 T10354
|
1395946-75-4
|
Razuprotafib
|
Razuprotafib
|
1008510-37-9
|
Olutasidenib
|
OLUTASIDENIB
|
1887014-12-1
|
L-Valyl-L-phenylalanine
|
H-VAL-PHE-OH
|
3918-92-1
|
Furprofen
|
FURPROFEN
|
66318-17-0
|
Raleukin
|
阿那白滯素
|
143090-92-0
|
BCI hydrochloride
|
(E/Z)-BCI HYDROCHLORIDE
|
95130-23-7
|
CA-170
|
化合物 T12378L
|
1673534-76-3
|
L-NIL
|
L-NIL
|
53774-63-3
|
N6,N6-Dimethyladenosine
|
N6,N6-二甲基腺苷
|
2620-62-4
|
PF-03654764
|
化合物 PF-03654764
|
935840-35-0
|
Obafistat
|
化合物OBAFISTAT
|
2160582-57-8
|
Pexacerfont
|
8-(6-甲氧基-2-甲基-3-吡啶基)-2,7-二甲基-N-[(1R)-1-甲基丙基]吡唑并[1,5-A]-1,3,5-三嗪-4-胺
|
459856-18-9
|
PF-4878691
|
532959-63-0
|
532959-63-0
|
Etomoxir
|
乙莫克舍
|
124083-20-1
|
SPL-707
|
SPL-707
|
2195361-33-0
|
AS2717638
|
AS2717638
|
2148339-28-8
|
PS10
|
PS10
|
1564265-82-2
|
N6-Etheno 2'-deoxyadenosine
|
N6-亞乙烯基-2'-脫氧腺苷
|
68498-25-9
|
NIK SMI1
|
NIK SMI1
|
1660114-31-7
|
TMP778
|
化合物 T13172L
|
1422053-04-0
|
TRPV4 agonist-1 free base
|
4(3H)-Quinazolinone, 8-fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)-
|
2314467-59-7
|
IHVR-11029
|
3,4,5-Piperidinetriol, 1-[6-(2,5-difluorophenoxy)hexyl]-2-(hydroxymethyl)-, (2R,3R,4R,5S)-
|
1383152-30-4
|
c-di-AMP disodium
|
環(huán)二腺苷酸二鈉鹽
|
2734909-87-4
|
Patamostat
|
4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate
|
114568-26-2
|
Manitimus
|
202057-76-9
|
202057-76-9
|
BI-671800
|
2 - [ 4- [ 4 -(三氟甲基)苯甲酰胺基] ] ]苯甲基4,6 -二(二甲氨基) -嘧啶-5-乙酸
|
1093108-50-9
|
RIPA-56
|
RIPA-56
|
1956370-21-0
|
ARN 077
|
化合物 T10370
|
1373625-34-3
|
Tazanolast
|
他扎司特
|
82989-25-1
|
Ablukast
|
阿魯司特
|
96566-25-5
|
3'-Azido-3'-deoxy-5-fluorocytidine
|
3'-AZIDO-3'-DEOXY-5-FLUOROCYTIDINE
|
2095417-18-6
|
C-178
|
N-(二苯并[B,D]呋喃-3-基)-5-硝基呋喃-2-甲酰胺
|
329198-87-0
|
RGX-104
|
RGX-104
|
610318-54-2
|
BAY-218
|
CPD3504
|
2162982-11-6
|
LDC7559
|
LDC7559
|
2407782-01-6
|
EMD527040
|
EMD527040
|
851333-14-7
|
ZCZ011
|
ZCZ 011
|
1998197-39-9
|
Avelumab
|
阿維魯單抗
|
1537032-82-8
|
CU-CPT-9a
|
CU-CPT-9B, CPD2004
|
2165340-32-7
|
PF-06747711
|
化合物 T16495
|
1892576-58-7
|
RU-301
|
RU-301
|
1110873-99-8
|
Naltriben mesylate
|
化合物 T23054
|
122517-78-6
|
Linzagolix
|
林扎戈利
|
935283-04-8
|
PI3Kδ-IN-1
|
PI3Kδ-IN-1
|
1911564-39-0
|
SPD304 dihydrochloride
|
TNF-α inhibitor
|
1049741-03-8
|
SOCE inhibitor 1
|
SOCE inhibitor 1
|
2169316-15-6
|
ML604440
|
ML 604440
|
1140517-08-3
|
Roflupram
|
1-Butanone, 1-[4-(difluoromethoxy)-3-[(tetrahydro-3-furanyl)oxy]phenyl]-3-methyl-
|
1093412-18-0
|
(S)-Coriolic acid
|
13(S)-HYDROXYOCTADECA-9Z,11E-DIENOIC ACID
|
29623-28-7
|
Eliapixant
|
依利哌嗪
|
1948229-21-7
|
AZ2
|
AZ2
|
2231760-33-9
|
CP 376395
|
CP 376395
|
175140-00-8
|
PKA-IN-1
|
1-ACETAMIDO-4-CYANO-3-METHYLISOQUINOLINE
|
179985-52-5
|
SB-747651A dihydrochloride
|
SB-747651A二鹽酸鹽
|
1781882-72-1
|
UCB9608
|
(S)-4-(6-氨基-1-甲基-1H-吡唑并[3,4-D]嘧啶-4-基)-N-(4-甲氧基-2-甲基苯基)-3-甲基哌嗪-1-甲酰胺
|
1616413-96-7
|
N6-(2-Phenylethyl)adenosine
|
N6-PHENETHYLADENOSINE; N6-PHENYLETHYLADENOSINE
|
20125-39-7
|
(αR,8aS)-GSK1614343
|
化合物 T27451
|
1092476-84-0
|
J-2156 TFA
|
化合物 J-2156 TFA
|
2387505-73-7
|
Zetomipzomib maleate
|
ZETOMIPZOMIB MALEATE
|
2170983-62-5
|
A-770041
|
A-770041
|
869748-10-7
|
Verucerfont
|
3-(4-甲氧基-2-甲基苯基)-2,5-二甲基-N-[(1S)-1-(3-甲基-1,2,4-惡二唑-5-基)丙基]吡唑并[1,5-A]嘧啶-7-胺
|
885220-61-1
|
NOD-IN-1
|
1-甲苯磺酰-1H-吲哚-2-甲酸乙酯
|
132819-92-2
|
Icerguastat
|
化合物SEPHIN 1
|
951441-04-6
|
Zegocractin
|
CS-2907
|
1713240-67-5
|
INF4E
|
Benzenepropanoic acid, 2-chloro-b-hydroxy-a-methylene-, ethyl ester
|
88039-46-7
|
H-151
|
H-151
|
941987-60-6
|
TH1020
|
TH1020
|
1841460-82-9
|
JNJ-55308942
|
JNJ-55308942
(JNJ55308942)
|
2166558-11-6
|
SPR inhibitor 3
|
N-[2-(5-Hydroxy-2-methyl-1H-indol-3-yl)ethyl]-2-methoxyacetamide
|
1292285-54-1
|
MLT-748
|
MLT-748
|
1832578-30-9
|
Labetalol
|
拉貝洛爾
|
36894-69-6
|
BMS-470539 dihydrochloride
|
BMS 470539 DIHYDROCHLORIDE
|
2341796-82-3
|
Ly93
|
Ly93
|
1883528-69-5
|
Ensifentrine
|
Ensifentrine
|
1884461-72-6
|
CRAC intermediate 2
|
4-(3,5-雙(三氟甲基)-1H-吡唑-1-基)-苯胺
|
123066-64-8
|
Trimethylamine N-oxide-d9
|
N,N-Di(Methyl-d3)Methan-d3-aMine N-Oxide
|
1161070-49-0
|
(S)-Flurbiprofen
|
(S)-氟比洛芬
|
51543-39-6
|
GSK3179106
|
GSK3179106
|
1627856-64-7
|
TLR7 agonist 2
|
CS-2748
|
1642857-69-9
|
Synta66
|
化合物SYNTA66
|
835904-51-3
|
PAP-1
|
4-(4-苯氧基丁氧基)-7H-呋喃并[3,2-G][1]苯并吡喃-7-酮
|
870653-45-5
|
TC-S 7005
|
TC-S 7005
|
1082739-92-1
|
diABZI STING agonist-1 trihydrochloride
|
DIABZI STING AGONIST-1 TRIHYDROCHLORIDE
|
2138299-34-8
|
GSK 366
|
GSK366)
|
1953157-39-5
|
S18-000003
|
Benzeneacetamide, N-(2,4-difluorophenyl)-4-[[2-[4-(ethylsulfonyl)phenyl]acetyl]amino]-2-fluoro-α,α-dimethyl-
|
2068119-11-7
|
Paquinimod
|
帕奎莫德
|
248282-01-1
|
UNC0379
|
UNC0379
|
1620401-82-2
|
TAK1-IN-4
|
化合物HS220
|
1570374-32-1
|